Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03014427

Development of a Biological Database in the Field of Operative Intensive Care

Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
99,999,999 (estimated)
Sponsor
RWTH Aachen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.

Detailed description

The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary. Sample volumes are defined as follows: * Peripheral blood: up to a total of 150 ml distributed to a maximum of 10 morning blood samples (approximately 15 ml blood per blood sample) during the inpatient stay in the intensive care unit (fixed times are admission and discharge of the intensive care unit) * Urine: a total of up to 200 ml of catheter urine distributed to a maximum of 10 morning withdrawals during inpatient stays in the intensive care unit (defined times are admission and discharge from the intensive care unit)

Conditions

Interventions

TypeNameDescription
OTHERBiological DatabaseBiological Database

Timeline

Start date
2017-03-01
Primary completion
2050-02-01
Completion
2050-02-01
First posted
2017-01-09
Last updated
2019-09-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03014427. Inclusion in this directory is not an endorsement.

Development of a Biological Database in the Field of Operative Intensive Care (NCT03014427) · Clinical Trials Directory